TherapeuticsMD (TXMD) Operating Expenses (2010 - 2026)

TherapeuticsMD's Operating Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• Quarterly Operating Expenses fell 13.56% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (down 6.65% YoY) and the FY2025 annual result came in at $7.4 million, down 5.86% from the prior year.
• Operating Expenses was $1.4 million for Q1 2026 at TherapeuticsMD, down from $2.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $20.1 million in Q4 2022 and bottomed at $1.3 million in Q4 2024.
• A 5-year average of $5.5 million and a median of $2.1 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 125.87% — and 2023, when it slumped 89.5%.
• TherapeuticsMD's Operating Expenses stood at $20.1 million in 2022, then slumped by 89.5% to $2.1 million in 2023, then slumped by 37.58% to $1.3 million in 2024, then jumped by 85.37% to $2.4 million in 2025, then tumbled by 40.82% to $1.4 million in 2026.
• Business Quant data shows TXMD's Operating Expenses at $1.4 million in Q1 2026, $2.4 million in Q4 2025, and $1.6 million in Q3 2025.